4//SEC Filing
Hager Jeffrey 4
Accession 0001567619-19-015483
CIK 0001676725other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 7:20 PM ET
Size
7.1 KB
Accession
0001567619-19-015483
Insider Transaction Report
Form 4
Hager Jeffrey
SVP, Chief Technology Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-07-26−5,197→ 10,396 totalExercise: $4.31Exp: 2028-04-12→ Common Stock (5,197 underlying) - Exercise/Conversion
Common Stock
2019-07-26$4.31/sh+5,197$22,399→ 127,853 total
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from February 27, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
IDEAYA Biosciences, Inc.
CIK 0001676725
Entity typeother
Related Parties
1- filerCIK 0001777424
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 7:20 PM ET
- Size
- 7.1 KB